亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

Actin from rabbit muscle

 
 
單價 面議對比
詢價 暫無
發(fā)貨 上海付款后3天內
品牌 上海一研
≥99.0% 10CM*20CM
過期 長期有效
更新 2021-04-28 15:30
 

上海一研生物科技有限公司

企業(yè)會員第6年
資料未認證
保證金未繳納
  • 上海
  • 上次登錄 2023-10-10
  • 吳小姐 (先生)  
詳細說明
英文名稱: Actin from rabbit muscle 
產(chǎn)品規(guī)格: BR,85% 
包裝: 1毫克/5毫克/25毫克 
CAS號:51005-14-2
分子量:43 kDa
級別:BR
含量:≥85% (SDS-PAGE)
蛋白含量:≥80%(biuret) 
性狀:普遍存在于各類細胞的細胞核中。肌肉結構蛋白的一種,肌原纖維細絲中的主要成分。它是由一條多肽鏈組成。分子構型呈球形,有方向性,一般稱球狀肌動蛋白(G-肌動蛋白);當增加溶液的離子強度,在Mg2+存在下,許多個(300~400)G-肌動蛋白按同一前后方向聚合成長鏈,稱為纖維狀-肌動蛋白(F-肌動蛋白)。在肌原纖維細絲中,以兩條F-肌動蛋白鏈相互盤繞成雙股螺旋
用途:生化研究。肌動蛋白、肌動蛋白結合蛋白和肌動蛋白相關蛋白等蛋白共同參與了細胞核內肌動蛋白形式和功能的調節(jié),包括肌動蛋白單體與聚合形式的轉換、染色質結構調整、基因轉錄調控、mRNA加工和運輸?shù)仍S多重要生理功能。
保存:2~8℃

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
曲拉通x-405 潤濕劑P-40 曲拉通x-100 曲拉通x-114 曲拉通x-200 曲拉通x-405 潤濕劑P-40 OED60K型發(fā)酵工業(yè)通用消泡劑
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |